Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
暂无分享,去创建一个
Dinesh Kumar | Dinesh Kumar | N. Shastri | Nalini R Shastri | S V Sailaja Chirravuri | S. V. Sailaja Chirravuri
[1] P. Tran,et al. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility , 2010, Expert opinion on drug delivery.
[2] K. Dua,et al. Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac , 2011, Journal of pharmacy & bioallied sciences.
[3] B. Yılmaz,et al. Method for Determination of Diclofenac in Human Plasma and Its Application to a Pharmacokinetic Study in Turkey , 2011 .
[4] J. B. Higgins,et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates , 1992 .
[5] S. Mutalik,et al. Preparation,In vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac , 2007, Archives of pharmacal research.
[6] D. Avnir,et al. Recommendations for the characterization of porous solids (Technical Report) , 1994 .
[7] J Dressman,et al. Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] X. Ponsoda,et al. Metabolism of aceclofenac in humans. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[9] M. Fröba,et al. Silica-based mesoporous organic-inorganic hybrid materials. , 2006, Angewandte Chemie.
[10] Mark E. Davis,et al. Studies on mesoporous materialsI. Synthesis and characterization of MCM-41 , 1993 .
[11] G. Levy. EFFECT OF CERTAIN TABLET FORMULATION FACTORS ON DISSOLUTION RATE OF THE ACTIVE INGREDIENT. I. IMPORTANCE OF USING APPROPRIATE AGITATION INTENSITIES FOR IN VITRO DISSOLUTION RATE MEASUREMENTS TO REFLECT IN VIVO CONDITIONS. , 1963, Journal of pharmaceutical sciences.
[12] F. Marmottini,et al. Role of mesoporous silicates on carbamazepine dissolution rate enhancement , 2008 .
[13] Wendy I. Wilson,et al. Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents. , 2007, Journal of pharmaceutical sciences.
[14] W. Maier,et al. Characterization of micro- and mesoporous solids by physisorption methods and pore-size analysis , 1998 .
[15] R. Prins,et al. A mechanistic explanation of the formation of high quality MCM-41 with high hydrothermal stability , 2003 .
[16] J. Devoisselle,et al. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] N. Chotai,et al. Development of Discriminating Method for Dissolution of Aceclofenac Marketed Formulations , 2008 .
[18] Youssef Belmabkhout,et al. Effect of pore expansion and amine functionalization of mesoporous silica on CO2 adsorption over a wide range of conditions , 2009 .
[19] Patrick Augustijns,et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] K. A. Khan. The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.
[21] F. Wang,et al. Effects of post-synthesis treatments on the pore structure and stability of MCM-41 mesoporous silica , 2007 .
[22] V. B. Fenelonov,et al. Mesopore size and surface area calculations for hexagonal mesophases (types MCM-41, FSM-16, etc.) using low-angle XRD and adsorption data , 1999 .
[23] Andrea C. Santomaso,et al. Powder flowability and density ratios: the impact of granules packing , 2003 .
[24] Shaobin Wang,et al. Ordered mesoporous materials for drug delivery , 2009 .
[25] Q. Huo,et al. Surfactant Control of Phases in the Synthesis of Mesoporous Silica-Based Materials , 1996 .
[26] Siling Wang,et al. Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties. , 2011, International journal of pharmaceutics.
[27] Keith P. Johnston,et al. Improvement of Dissolution Rates of Poorly Water Soluble APIs Using Novel Spray Freezing into Liquid Technology , 2002, Pharmaceutical Research.
[28] J. Zink,et al. Mesoporous silicate materials as substrates for molecular machines and drug delivery , 2008 .
[29] M. Vallet‐Regí,et al. Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .
[30] N. G. Popovich,et al. Pharmaceutical Dosage Forms and Drug Delivery Systems , 1990 .
[31] Patrick Augustijns,et al. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. , 2007, Chemical communications.
[32] K. Srinivasan,et al. High-performance liquid chromatography and pharmacokinetics of aceclofenac in rats. , 2007, Analytica chimica acta.
[33] S. Mutalik,et al. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach. , 2008, International journal of pharmaceutics.
[34] K. Sing. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984) , 1985 .
[35] Jean-Marie Devoisselle,et al. Solid-State NMR Study of Ibuprofen Confined in MCM-41 Material , 2006 .
[36] Mark E. Davis,et al. Studies on mesoporous materials II. Synthesis mechanism of MCM-41 , 1993 .
[37] G. Herrero-Beaumont,et al. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis , 1994, Agents and Actions.
[38] F. Schüth,et al. Ordered mesoporous materials , 1999 .
[39] P. Costa,et al. Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[40] G. Germain,et al. Crystal structure and spectroscopic study of 2-[(2,6-dichlorophenyl)amino]phenylacetoxyacetic acid (Aceclofenac) , 1992 .
[41] V. Sinha,et al. A simple and sensitive stability-indicating RP-HPLC assay method for the determination of aceclofenac. , 2008, Journal of chromatographic science.
[42] K. Shaikh,et al. Simultaneous determination of aceclofenac, paracetamol, and chlorzoxazone by RP-HPLC in pharmaceutical dosage form. , 2008, Journal of chromatographic science.
[43] R. Bodmeier,et al. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.